Total 48Articles, Present Page 1/5
				
				
				- 
							
								48Korean Pharmacopoeia (Twelfth Edition)Korean Pharmacopoeia (Twelfth Edition)- 
											01_KP Cover.pdf
- 
											02_[Appendix 1] General Notices.pdf
- 
											03_[Appendix 2] General Requirements for Pharmaceutical Preparations.pdf
- 
											04_[Appendix 3] Monographs_Part1.pdf
- 
											05_[Appendix 4] Monographs_Part2.pdf
- 
											06_[Appendix 5] General Tests.pdf
- 
											07_[Appendix 6] General Information.pdf
- 
											08_Index.pdf
 2024-01-31
- 
											
- 
							
								47Enforcement Rule of the Regulations on Relief of Injury from Side Effects of Drugs(No. 1783)Enforcement Rule of the Regulations on Relief of Injury from Side Effects of Drugs(No. 1783)- 
											Enforcement Rule of the Regulations on Relief of Injury from Side Effects of Drugs(No. 1783).pdf
 2023-08-29
- 
											
- 
							
								46The Enforcement Rule of the Narcotics Control Act (No. 1781)The Enforcement Rule of the Narcotics Control Act (No. 1781)- 
											The Enforcement Rule of the Narcotics Control Act (No. 1781).pdf
 2023-08-07
- 
											
- 
							
								45Regulations on the Criteria for Classification of Drugs(MFDS Notification No.2019-55, July 1, 2019)Regulations on the Criteria for Classification of Drugs(MFDS Notification No.2019-55, July 1, 2019)- 
											Regulations on the Criteria for Classification of Drugs (No. 2019-55).pdf
 2023-05-31
- 
											
- 
							
								44Designation of Drugs Not Eligible for Allowances for Relief of Injury from Adverse Drug Reaction(MFDS Notification, No.2017-62, 25 July 2017)Designation of Drugs Not Eligible for Allowances for Relief of Injury from Adverse Drug Reaction(MFDS Notification, No.2017-62, 25 July 2017)- 
											Designation of Drugs Not Eligible for Allowances for Relief of Injury from Adverse Drug Reaction (No.2017-62).pdf
 2023-05-31
- 
											
- 
							
								43Guideline on Re-Examination Affairs of New Drug,etc.Guideline on Re-Examination of New Drug,etc.(Nov 18, 2021)- 
											Guideline on Re-Examination of New Drugs etc. (Nov 18,2021).pdf
 2023-03-27
- 
											
- 
							
								42Regulation on the Labeling of Medicinal Products,etc.Regulation on the Labeling of Medicinal Products,etc.(No.2020-82, Sep 7, 2020)- 
											Regulation on the Labeling of Medicinal Products, etc.(No.2020-82, Sep 7,2020).pdf
 2023-03-27
- 
											
- 
							
								41Regulation on Good Manufacturing Practices (GMP) for Medicinal ProductsRegulation on Good Manufacturing Practices (GMP) for Medicinal Products.(No.2021-87, Nov 4, 2021)- 
											Regulation on Good Manufacturing Practices (GMP) for Medicinal Products (No.2021-87, Nov 4,2021).pdf
 2023-03-27
- 
											
- 
							
								40Regulation on Fees for Pharmaceutical Approval, etc.Regulation on Fees for Pharmaceutical Approval, etc.(No.2022-46, Jun 27, 2022)- 
											Regulation on Fees for Pharmaceutical Approval, etc.(No.2022-46, Jun 27, 2022).pdf
 2023-03-27
- 
											
- 
							
								39Regulation on Approval for Investigational New Drug Application of Drugs.Regulation on Approval for Investigational New Drug Application of Drugs.(No.2022-81, Nov 23, 2022)- 
											Regulation on Approval for Investigational New Drug Application of Drugs(No.2022-81, Nov 23, 2022).pdf
 2023-03-27
- 
											

